Two-Year Outcomes and Biomarker Analysis of Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma After Neoadjuvant Chemotherapy and Immunotherapy from the Phase II WuhanUHGI001 Trial
Xiong Sun(Union Hospital), Kaixiong Tao(Union Hospital), Anshu Li(Union Hospital), Jianbo Lyu(Union Hospital), Ke Wu(Union Hospital), Lin Yao(Union Hospital), Zheng Wang(Union Hospital), Ming Yang(Union Hospital), Guobin Wang(Union Hospital), Yuping Yin(Union Hospital), Peng Zhang(Huazhong University of Science and Technology), Kailin Cai(Union Hospital), Ke Liu(Anhui Medical University), Xiaoming Shuai(Union Hospital)
Cited by 14
Related Papers
Gasdermin D permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis
|Immunity|2023|484
Maresin1 Protect Against Ferroptosis-Induced Liver Injury Through ROS Inhibition and Nrf2/HO-1/GPX4 Activation
|Frontiers in Pharmacology|2022|202
Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action
|Molecular Cancer|2009|131
Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk
|Frontiers in Immunology|2024|92